首页> 外国专利> A STUDY ON THE CYTOTOXIC EFFECT AND EFFICIENT INHIBITION OF CELL CYCLE PROGRESSION OF THE HUMAN BREAST AND LUNG CANCER CELL LINES BY THE DEVELOPED NANO-GELATIN ENCAPSULATED GLUTATHIONE REDUCTASE AND LYCOPENE (IN-VITRO)

A STUDY ON THE CYTOTOXIC EFFECT AND EFFICIENT INHIBITION OF CELL CYCLE PROGRESSION OF THE HUMAN BREAST AND LUNG CANCER CELL LINES BY THE DEVELOPED NANO-GELATIN ENCAPSULATED GLUTATHIONE REDUCTASE AND LYCOPENE (IN-VITRO)

机译:纳米明胶包裹的谷胱甘肽还原酶和番茄红素(体外)对人乳腺癌和肺癌细胞株的细胞毒作用和对细胞周期的有效抑制研究

摘要

Cancer is the most dreaded disease and is the second leading cause of death worldwide and accounted for 7.6 million deaths (around 13 per cent of all deaths) occurred in low and middle income countries in 2008. Fatalities from cancer worldwide are projected to continue to rise to over 13.1 million in 2030. Based on the current rate of incidence, it is believed that one in every three persons will develop cancer at some time during his life. Nanotechnology is a useful tool for developing ways to eradicate cancer cells without harming healthy, neighbouring cells. Nanotechnology offers a more targeted approach and this could provide significant benefits to cancer patients, hi fact, the use of nanoparticles for drug delivery and targeting is likely one of the most exciting and clinically important applications of cancer nanotechnology. So it was thought of interest to make an attempt to develop nano-gelatin encapsulated GR and Lycopene from the commonly consumed food, tomato in combating cancer by sustaining their stability, as nanomedicine in future would play a crucial role in treatment of human diseases and also in enhancement of normal human physiology. From the results obtained in the study, it is evident that there was a feasibility of synthesizing nano-gelatin encapsulated GR and Lycopene and these compounds were found to be stable at 4°C for a period of more than 90 days and also the nano-size of 100 nm of these compounds was evident through characterization using UV-Visible spectroscopy, SEM and FTIR analysis. It was exciting to note that both Glutathione Reductase and Lycopene in nano-gelatin encapsulated forms proved to have more cytotoxicity and are also capable of efficiently inhibiting the cell cycle progression at various phases of the cell cycle in human breast and lung cancer cells when compared to the extracted forms. Apart fi-om this both the encapsulated compounds were found to be non-toxic to normal vero (healthy) cells. Abbreviation - GR - Glutathione Reductase, SEM - Scanning electron microscopy, FTIR - Fourier transform infrared spectroscopy.
机译:癌症是最可怕的疾病,并且是全世界第二大死亡原因,2008年,低收入和中等收入国家的死亡人数为760万人(约占所有死亡人数的13%)。全世界范围内的癌症死亡人数预计将继续增加到2030年将超过1310万。根据目前的发病率,据信每三个人中就有一个在他一生中的某个时候患上癌症。纳米技术是开发消灭癌细胞而不损害健康的邻近细胞的方法的有用工具。纳米技术提供了一种更具针对性的方法,这可以为癌症患者带来重大利益。事实上,使用纳米颗粒进行药物递送和靶向治疗可能是癌症纳米技术最令人兴奋且临床上最重要的应用之一。因此,人们认为,尝试从常用食品番茄中开发纳米明胶包裹的GR和番茄红素,以维持其抗癌性,因为将来纳米医学将在人类疾病的治疗中起着至关重要的作用。在增强人类正常生理方面。从研究中获得的结果,很明显,合成纳米明胶封装的GR和番茄红素是可行的,并且发现这些化合物在4°C稳定90天以上,并且纳米通过使用紫外可见光谱,SEM和FTIR分析进行表征,可以明显看出这些化合物的100 nm尺寸。令人兴奋的是,与之相比,纳米明胶封装形式的谷胱甘肽还原酶和番茄红素均具有更高的细胞毒性,并且还能够有效抑制人乳腺癌和肺癌细胞在细胞周期各个阶段的细胞周期进程。提取的表格。此外,还发现这两种封装的化合物对正常的vero(健康)细胞无毒。缩写-GR-谷胱甘肽还原酶,SEM-扫描电子显微镜,FTIR-傅里叶变换红外光谱。

著录项

  • 公开/公告号IN2012CH03233A

    专利类型

  • 公开/公告日2012-08-24

    原文格式PDF

  • 申请/专利权人

    申请/专利号IN3233/CHE/2012

  • 发明设计人 MARY ANNE PREETHA K;

    申请日2012-08-07

  • 分类号B82Y15/00;A16K31/00;

  • 国家 IN

  • 入库时间 2022-08-21 17:23:59

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号